Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Tempus AI, Inc. Expands Data Agreements with BMS and Pathos AI
Oct 23, 2026
Contract Type
licensing
ChicagoOtherBiotechnology
Description
Tempus AI, Inc. has entered into agreements with Bristol-Myers Squibb Company and Pathos AI, Inc. to enhance access to its de-identified data in oncology and to license neurology data for collaborative purposes. The agreements include a Statement of Work and an Order Form, providing for aggregate cash payments of $192.5 million over five years
Company Information
Company
Tempus AI
Location
Chicago, Illinois, United States
About
Tempus AI, Inc. is a leader in artificial intelligence and precision medicine.